
Oxford Nanopore Technologies is seeking a Senior Director of Product Management to lead the strategy, lifecycle management, and commercial success of our sequencing systems portfolio. This role is accountable for both on-market sequencing platforms and new product introductions, ensuring products deliver clear customer value, align with company strategy, and are successfully developed, launched, and sustained at scale.
The role sits at the intersection of technology, science, and commercial execution, working closely with R&D, Product Development, Commercial, Marketing, Operations, and Regulatory teams. The successful candidate will bring strong leadership, strategic thinking, and deep experience managing complex, hardware-enabled product portfolios in a fast-moving, innovation-driven environment.
Key Responsibilities
Product Strategy & Portfolio Leadership
On-Market Product Leadership
New Product Introductions
Cross-Functional Leadership
Team Leadership & Capability Building
Required Experience & Skills
Desirable Experience
Why Oxford Nanopore
Oxford Nanopore Technologies is redefining what’s possible in sequencing, enabling real-time, accessible analysis of DNA and RNA. This role offers the opportunity to shape the future of sequencing systems at scale, working with world-class scientists, engineers, and commercial teams to deliver products that have global scientific and societal impact.
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.

Our goal is to enable the analysis of anything, anywhere, by anyone.
We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.
Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide.
Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.